Effect of Sodium Glucose Co-transporter 2 Inhibitors on Left Atrial Remodeling in Diabetic Patients

ConditionSGLT 2 Inhibitors

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age40-75

SponsorAssiut University

About this trial

To evaluate and follow-up left atrial volume, diastolic function by 2D echocardiography and left atrial strain parameters using speckle-tracking echocardiography in patients with type 2 diabetes mellitus (T2DM) before and after treatment with SGLT2 inhibitors

Eligibility criteria

Qualifiers

Diagnosed T2DM on antidiabetic medication not including SGLT2 inhibitors.

HbA1c ≤ 7%.

Age 40-75 years.

Sinus rhythm.

Disqualifiers

History of atrial fibrillation or flutter.

Patients treated with SGLT2 inhibitors.

Severe mitral valve regurgitation or stenosis.

Previous myocardial infarction.

Trial design

Treatments tested in this trial

Sodium Glucose Co-transporter 2 (SGLT2) Inhibitor

Treatment groups

No treatment groups listed

Locations

This trial has no locations

Sponsors and collaborators

Assiut University

Lead sponsor

Source ClinicalTrials.gov